EPIVIR
lamivudine
- Strength
- 300 mg/1
- Form
- Tablet, Film Coated
- Class
- Hepatitis B Virus Nucleoside Analog Rev…
ViiV Healthcare Company
Lamivudine
Listed by Ingenus Pharmaceuticals, LLC
- Strength
- 300 mg/1
- Form
- Tablet
- Route
- Oral
- Class
- Hepatitis B Virus Nucleoside Analog Reverse T…
What it contains
- Lamivudine 300 mg/1
FDA record
| Dosage form | Tablet |
|---|---|
| Route | Oral |
| Drug class | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor |
| Approval route | ANDA — approved generic |
| NDC code | 50742-624 |
| FDA application | ANDA206974 |
| RxNorm concept | 199147 |
| Package sizes listed | 1 |
| Marketed since | February 2017 |
Other products containing Lamivudine
See allSame active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
EPIVIR
lamivudine
- Strength
- 10 mg/mL
- Form
- Solution
- Class
- Hepatitis B Virus Nucleoside Analog Rev…
ViiV Healthcare Company
EPIVIR
lamivudine
- Strength
- 150 mg/1
- Form
- Tablet, Film Coated
- Class
- Hepatitis B Virus Nucleoside Analog Rev…
ViiV Healthcare Company
LAMIVUDINE
- Strength
- 150 mg/1
- Form
- Tablet, Film Coated
- Class
- Hepatitis B Virus Nucleoside Analog Rev…
Major Pharmaceuticals
Lamivudine
- Strength
- 100 mg/1
- Form
- Tablet, Film Coated
- Class
- Hepatitis B Virus Nucleoside Analog Rev…
Apotex Corp.
Lamivudine
- Strength
- 150 mg/1
- Form
- Tablet
- Class
- Hepatitis B Virus Nucleoside Analog Rev…
Ingenus Pharmaceuticals, LLC
Lamivudine
- Strength
- 150 mg/1
- Form
- Tablet, Film Coated
- Class
- Hepatitis B Virus Nucleoside Analog Rev…
Strides Pharma Science Limited
Lamivudine
- Strength
- 150 mg/1
- Form
- Tablet, Film Coated
- Class
- Hepatitis B Virus Nucleoside Analog Rev…
Coupler LLC
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.